506 related articles for article (PubMed ID: 34990423)
1. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
2. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
3. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
4. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
[TBL] [Abstract][Full Text] [Related]
5. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
6. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
[TBL] [Abstract][Full Text] [Related]
7. Bowel Functional Outcomes After Long-Course or Short-Course Radiation for Advanced Rectal Cancers: A Propensity-Matched Analysis.
Kazi M; Jajoo B; Kapadia R; Dohale S; Bhuta P; Desouza A; Saklani A
Dis Colon Rectum; 2022 Dec; 65(12):1494-1502. PubMed ID: 36382840
[TBL] [Abstract][Full Text] [Related]
8. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
9. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
[TBL] [Abstract][Full Text] [Related]
10. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
[TBL] [Abstract][Full Text] [Related]
11. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
[TBL] [Abstract][Full Text] [Related]
13. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
[TBL] [Abstract][Full Text] [Related]
15. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
17. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
[TBL] [Abstract][Full Text] [Related]
18. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
Antunez AG; Kanters AE; Regenbogen SE
Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
[TBL] [Abstract][Full Text] [Related]
19. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
[TBL] [Abstract][Full Text] [Related]
20. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
